Significados de major amputation en inglés

The primary end point was major amputation or death, whichever occurred first.

Diabetes mellitus, preoperative ulcer or gangrene were associated with need of major amputation.

Six patients underwent major amputation and 1 patient underwent minor amputation.

The study endpoint was major amputation within 3 months after PB-MNC.

One patient had to undergo major amputation and 2 minor amputations.

These differences were mainly driven by reintervention and restenosis rather than by major amputation.

Thus far poor prognosis has been reported for major amputation.

Additional assessments were conducted to identify risk factors for death and major amputation, including paclitaxel dose tercile.

Outcome was defined as event-free survival from the combined endpoint freedom from re-intervention, major amputation and death.

Secondary endpoints were early and late mortality and morbidity, primary graft patency, major amputation rates and patient survival.

The collected data were evaluated for correlation between patients with and without major amputation within 3 months after PB-MNC.

In 15 of 26, major amputation was the primary treatment.

The primary outcome event was the composite of nonfatal myocardial infarction, nonfatal ischemic stroke, major amputation, and cardiovascular death.

Wharton reports a case of triple major amputation on a negro of twenty-one, who was run over by a train.

Fontaine stage, TASC class and postoperative infection of operated limb increased the risk for loss of primary patency and major amputation.

This was borne out in the clinical scenario, where an indirect peroneal reperfusion of the AT angiosome resulted in major amputation.